Results 91 to 100 of about 135,604 (246)

Surgical Management of Multiglandular Parathyroid Disease

open access: yes, 2013
In 1934, Albright et al.[1] discovered the unusual entity of parathyroid water-clear–cell hyperplasia and thought this resulted from some form of extrinsic glandular stimulation. The more common parathyroid chief-cell hyperplasia was described in 1958 by
Stålberg, Peter,, Åkerström, Göran,
core  

A Case of Mediastinal Parathyroid Adenoma

open access: yes, 2015
Parathyroid adenomas are the most important cause of primary hyperparathyroidism. The diagnosis of primary hyperparathyroidism is established based on the combination of elevated serum calcium and parathyroid hormone levels.
Erkan Akar
core   +1 more source

Evaluation of Parathyroid allo-transplantation with the Presence of Auto-CASR Antibody

open access: yes, 2022
Objective:Parathyroid tissue is responsible for the regulation of calcium and vitamin D metabolism. It regulates parathyroid hormone release by the calcium-sensing receptor (CaSR) which is found on the parathyroid cell surface.
Harika SALEPÇIOĞLU KAYA   +11 more
core   +1 more source

Tumor‐Derived Exosomal piR‐hsa‐28212 Promotes Lymphatic Metastasis in Breast Cancer

open access: yesCancer Science, EarlyView.
Breast cancer–derived exosomal piR‐hsa‐28212 promotes lymphangiogenesis and lymph node metastasis by activating VEGFC/VEGFR3 signaling. It stabilizes TBX1 mRNA in lymphatic endothelial cells and METTL3 protein in tumor cells, enhancing VEGFR3 expression and VEGFC secretion.
Yafen Wang   +7 more
wiley   +1 more source

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5 [PDF]

open access: yes
: • This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours. • Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included.
Kaltsas, G   +44 more
core   +1 more source

MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10‐Mediated Angiogenesis

open access: yesCancer Science, EarlyView.
MEN1 deficiency promotes JunD‐mediated upregulation of MMP10 expression, which cleaves pro‐HB‐EGF and activates endothelial EGFR. This triggers the PI3K/Akt and MEK/ERK signaling pathways, thereby driving angiogenesis and tumor progression. MMP10 inhibitor treatment blocks this cleavage, suppresses EGFR signaling, and thereby delays malignant ...
Chengyu Wei   +17 more
wiley   +1 more source

Parathyroid adenomas and malignannt neoplasms: coincidence or etiological association?

open access: yes, 1997
Objective: To evaluate the possible association between primary hyperparathyroidism and malignant neoplasms. Design: An historical cohort study.
Rizzi, C   +5 more
core   +1 more source

Expression of TRAIL and Fas in Primary Hyperparathyroidism

open access: yesJournal of Investigative Surgery, 2017
Aim: Differentiating between parathyroid lesions is still difficult and ambiguous. In cases of primary hyperparathyroidism, appropriate and prompt diagnosis is of great importance for effective treatment and follow-up.
Oliwia Anna Segiet   +6 more
doaj   +1 more source

Parathyroid Cancer

open access: yes, 2012
Parathyroid carcinoma is a rare endocrine malignancy derived from the parenchymal cells of the parathyroid glands. It is usually associated with more severe and profound clinical and laboratory manifestations than its more common benign counterparts. Its
IACOBONE, MAURIZIO, HENRY JF
core   +1 more source

Adjustable Vocal Implant System (VOIS) for Unilateral Vocal Fold Paralysis: Short‐Term Outcomes From a 12‐Patient Case Series

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Background Unilateral vocal cord palsy (UVCP) significantly affects phonation and swallowing. While injection laryngoplasty and medialisation thyroplasty are effective, both may require revision. Vocal Implant System (VOIS; APrevent Biotech GmbH) is an adjustable titanium‐silicone thyroplasty implant that allows postoperative modification ...
Sam Kebbe   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy